Categories AlphaGraphs, Consumer, Earnings
Earnings: A snapshot of Lennar’s (LEN) Q1 2022 financial results
Lennar Corporation (NYSE: LEN) on Wednesday announced first-quarter 2022 financial results, reporting higher revenues. The top-line also exceeded consensus estimates.
Net income attributable to the company was $503.6 million or $1.69 per share in the first three months of fiscal 2022, compared to $1.0 billion or $3.20 per share last year. Excluding special items, earnings increased to $2.70 per share from $2.04 per share in the prior-year period.
Revenues increased 16% year-over-year to $6.2 billion during the three-month period, and deliveries rose 2% to 12,538 homes. Analysts were looking for slower top-line growth.
“The impact of supply chain issues and increased cycle times were partially offset by accelerated construction starts. We continue to strategize with our national supply vendors and local trades to minimize these ever-changing challenges and are confident that we will successfully navigate through these unique dynamics,” said Jon Jaffe, co-chief executive officer of Lennar.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications